vector
base
differ
serotyp
adenoassoci
viru
hold
great
promis
human
gene
therapi
base
uniqu
tissu
tropism
distinct
immunolog
profil
particularli
interest
candid
effici
rapidli
transduc
wide
rang
tissu
vivo
unravel
mechan
behind
transduct
use
yeast
twohybrid
analys
screen
mous
liver
complementari
dna
librari
cellular
protein
capabl
interact
viral
capsid
protein
total
recov
approxim
clone
compris
independ
gene
sequenc
analys
reveal
multipl
hit
gene
includ
two
encod
endosom
cystein
proteas
cathepsin
b
l
notabl
two
proteas
also
physic
interact
correspond
portion
capsid
yeast
demonstr
cathepsin
b
l
essenti
effici
transduct
mammalian
cell
document
abil
purifi
cathepsin
b
l
protein
bind
cleav
intact
particl
vitro
data
suggest
cathepsinmedi
cleavag
could
prime
aav
capsid
subsequ
nuclear
uncoat
indic
analysi
addit
gene
recov
screen
may
help
elucid
mechan
behind
transduct
relat
serotyp
twohybrid
screen
identifi
cathepsin
b
l
uncoat
factor
adenoassoci
viru
introduct
adenoassoci
viru
nonpathogen
viru
belong
parvoviru
famili
also
includ
canin
parvoviru
minut
viru
mice
human
viru
howev
aav
distinguish
famili
member
dependoviru
abl
replic
produc
viral
particl
presenc
helper
viru
adenoviru
aav
particl
compos
kb
singlestrand
dna
genom
enclos
within
nonenvelop
icosahedr
capsid
nm
diamet
sixti
subunit
structur
capsid
protein
assembl
ratio
form
intact
viral
capsid
vector
deriv
aav
particularli
power
promis
tool
human
gene
transfer
owe
high
safeti
vector
devoid
wildtyp
gene
integr
low
frequenc
abil
mediat
sustain
gene
express
variou
cell
type
recent
use
aav
vector
enhanc
isol
novel
aav
serotyp
encapsid
recombin
aav
genom
viral
variant
typic
result
vector
particl
character
distinct
tissu
tropism
immunolog
profil
outstand
exampl
provid
serotyp
isol
rhesu
monkey
shown
recent
plethora
report
vector
pseudotyp
mediat
unusu
robust
sustain
transgen
express
numer
tissu
includ
liver
heart
skelet
muscl
particular
yield
higher
transduct
level
liver
aav
despit
aminoacid
homolog
two
capsid
surpris
current
gain
increas
popular
vector
vivo
transduct
multipl
tissu
speci
consid
clinic
evalu
human
howev
despit
grow
interest
particular
aav
serotyp
littl
known
mechan
transduct
fact
insight
variou
step
cellular
aav
infect
stem
studi
conduct
aav
famili
prototyp
initi
step
typic
involv
attach
cell
surfac
via
bind
one
primari
secondari
receptor
molecul
heparan
sulfat
proteoglycan
integrin
fibroblast
hepatocyt
growth
factor
receptor
contrast
preferenti
attach
cell
bind
sialic
acid
plateletderiv
growth
factor
receptor
explain
distinct
tissu
tropism
display
serotyp
bind
cell
surfac
also
appear
activ
intracellular
signal
pathway
subsequ
trigger
intern
viru
receptormedi
endocytosi
small
gtpbind
protein
key
player
process
activ
essenti
viru
uptak
cell
subsequ
cell
entri
particl
proce
endosom
compart
traffic
either
late
recycl
endosom
two
factor
influenc
local
particl
within
differ
endosom
subcompart
viral
dose
administ
cell
type
contrast
report
accumul
golgi
compart
follow
endocytosi
cell
surfac
suggest
aav
serotyp
util
distinct
transduct
pathway
traffick
endosom
critic
step
particl
inject
directli
cytoplasm
express
viral
genom
addit
treatment
block
acidif
endosom
compart
caus
signific
decreas
transduct
collect
studi
suggest
proper
aav
endosom
process
may
serv
prime
viral
capsid
downstream
step
nuclear
transport
andor
uncoat
virion
follow
endosom
escap
particl
travel
perinuclear
compart
step
probabl
facilit
atpdepend
molecular
motor
ubiquitinproteasom
pathway
appear
involv
uncoat
andor
nuclear
transloc
aav
ubiquitin
capsid
protein
report
fact
proteasom
inhibitor
enhanc
nuclear
aav
uptak
insid
nucleu
aav
eventu
uncoat
releas
genom
allow
subsequ
transcript
replic
case
process
slow
ineffici
probabl
one
major
limit
factor
transduct
recombin
contrast
virion
uncoat
much
rapidli
like
explain
robust
transduct
effici
understand
mechan
behind
transduct
conduct
yeast
twohybrid
screen
host
cellular
protein
abl
physic
interact
capsid
protein
report
identif
respect
candid
includ
two
particularli
interest
clone
encod
endosom
cystein
proteas
cathepsin
b
l
use
cathepsinspecif
inhibitor
abl
show
activ
import
transduct
mammalian
cell
play
similar
role
moreov
vitro
assay
found
cathepsin
bound
cleav
capsid
either
serotyp
creat
virusspecif
restrict
pattern
data
suggest
cathepsin
b
l
involv
differenti
endosom
process
may
prime
virion
subsequ
nuclear
disassembl
prerequisit
transgen
express
twohybrid
screen
identifi
interact
partner
capsid
protein
gain
insight
mechan
transduct
conduct
yeast
twohybrid
screen
identifi
host
cellular
protein
capabl
interact
portion
capsid
fuse
dnabind
domain
portion
capsid
homolog
region
capsid
contain
expos
residu
result
bait
encod
residu
capsid
protein
use
screen
mous
liver
activ
domain
librari
highli
stringent
condit
requir
activ
two
differ
report
gene
suffici
yeast
cell
transform
bait
librari
contain
estim
million
clone
plasmid
provid
coverag
librari
recov
clone
capabl
activ
report
gene
allow
cell
grow
select
media
figur
sequenc
analys
plasmid
dna
clone
reveal
ident
differ
gene
among
repeatedli
recov
multipl
independ
coloni
list
tabl
suggest
interact
bait
strong
genuin
protein
encod
gene
belong
wide
rang
protein
class
figur
includ
plasma
membran
protein
potenti
act
viral
receptor
cell
surfac
proteas
could
theoret
contribut
viral
uncoat
aav
cellular
transduct
fact
two
particularli
interest
candid
recov
screen
cathepsin
b
l
endosom
protein
previous
implic
uncoat
numer
virus
ebola
reoviru
aav
transduct
depend
viru
traffick
endosom
decid
investig
potenti
role
two
cathepsin
step
aav
life
cycl
capsid
protein
interact
specif
prey
first
aim
verifi
specif
screen
determin
rel
strength
interact
therefor
measur
activ
lacz
report
gene
yeast
transform
bait
sever
clone
interest
recov
screen
includ
encod
cathepsin
b
l
proteas
well
clone
encod
histidinerich
glycoprotein
serum
adaptor
protein
thought
mediat
attach
cell
surfac
heparan
sulfat
proteoglycan
dazassoci
protein
cytoplasm
factor
thought
involv
cell
signal
importin
result
compar
bait
plasmid
contain
homolog
region
capsid
similar
respect
empti
bait
plasmid
shown
figur
activ
recov
clone
bait
significantli
higher
threeto
sevenfold
compar
empti
control
confirm
interact
independ
protein
domain
inde
specif
interestingli
bait
also
abl
interact
candid
prey
result
surpris
light
larg
sequenc
similar
capsid
contrast
report
gene
activ
capsid
bait
significantli
differ
empti
plasmid
control
test
clone
includ
cathepsinencod
prey
exampl
conclud
major
physic
interact
identifi
screen
inde
specif
cathepsin
b
l
involv
function
transduct
confirm
interact
capsid
protein
cathepsin
b
l
yeast
sought
determin
whether
two
proteas
play
role
transduct
mammalian
cell
end
incub
murin
fibroblast
cell
cellperm
cathepsin
inhibitor
preferenti
block
cathepsin
b
activ
also
inhibit
cathepsin
l
high
dose
four
hour
later
gfpencod
vector
ad
cell
number
green
fluoresc
protein
gfpexpress
cell
determin
day
later
compar
sampl
infect
absenc
inhibitor
interestingli
transduct
significantli
reduc
three
time
nasal
embryon
lhrh
factor
genbank
access
number
fourteen
gene
unknown
function
recov
screen
list
along
number
clone
recov
parenthes
dosedepend
manner
treatment
figur
suggest
cathepsin
b
l
activ
import
transduct
two
serotyp
result
valid
use
seri
control
experi
firstli
assay
conduct
gfp
observ
decreas
vector
transduct
high
dose
inhibitor
mm
appar
inhibitori
effect
like
nonspecif
use
lower
inhibitor
dose
mm
actual
result
slight
increas
gfp
transduct
secondli
transfect
cell
plasmid
express
destabil
gfp
protein
halflif
h
treatment
likewis
observ
margin
increas
number
gfpposit
cell
rule
inhibitori
effect
gene
express
drug
per
se
thirdli
test
noncellperm
version
drug
well
cathepsin
l
inhibitor
zphetyr
tbu
diazomethyl
keton
found
signific
chang
transduct
effici
vector
data
shown
studi
role
cathepsin
b
l
transduct
cell
transfect
cathepsin
b
l
express
plasmid
infect
aav
gfp
vector
use
western
blot
analysi
confirm
cell
transfect
express
vector
increas
level
cathepsin
b
l
compar
control
cell
transfect
empti
plasmid
data
shown
transduct
vector
increas
least
twofold
cell
overexpress
cathepsin
b
l
wherea
signific
chang
seen
vector
figur
confirm
cathepsin
b
l
activ
import
infect
vitro
cleavag
aav
particl
cathepsin
b
l
establish
function
role
cathepsin
b
l
cellular
transduct
next
measur
abil
purifi
cathepsin
bind
cleav
assembl
aav
particl
end
treat
recombin
particl
aav
serotyp
purifi
cathepsin
b
cathepsin
l
control
cystein
proteas
recov
screen
cathepsin
viral
protein
analyz
western
blot
use
polyclon
antibodi
recogn
capsid
protein
three
serotyp
expect
found
strong
reduct
level
fulllength
protein
incub
cathepsin
b
l
result
consist
predict
cleavag
viral
capsid
protein
two
proteas
figur
importantli
specif
cleavag
confirm
cathepsin
neg
control
level
remain
stabl
otherwis
ident
experiment
condit
moreov
addit
cathepsin
inhibitor
reaction
abolish
aav
capsid
cleavag
cathepsin
b
l
confirm
activ
respons
observ
digest
figur
final
none
three
test
cathepsin
abl
cleav
protein
result
consist
twohybrid
data
indic
capsid
bait
counterpart
could
physic
interact
cathepsin
prey
cathepsin
cleavag
pattern
aav
serotyp
specif
although
cathepsin
b
l
gener
similar
cleavag
product
within
given
aav
serotyp
observ
exact
peptid
pattern
differ
two
viral
isol
analyz
phenomenon
detail
resolv
digest
capsid
protein
highpercentag
polyacrylamid
gel
follow
immunoblot
two
distinct
antibodi
allow
us
differenti
ctermin
peptid
fragment
upstream
cleavag
product
found
capsid
digest
two
fragment
approxim
kda
size
upper
band
ctermin
fragment
evidenc
recognit
antibodi
bind
epitop
found
cterminu
figur
contrast
particl
digest
result
three
predomin
band
size
approxim
kda
detect
polyclon
serum
addit
note
fourth
band
around
kda
upon
overexposur
blot
fainter
band
hypothes
polypeptid
contain
fewer
epitop
bound
polyclon
antibodi
interestingli
upon
overexposur
blot
undigest
sampl
also
display
trace
amount
cleavag
product
one
possibl
explan
observ
purifi
aav
vector
contain
small
subpopul
viral
capsid
process
cellular
cathepsin
purif
sum
cleavag
product
band
exceed
size
fulllength
protein
kda
reason
one
probabl
repres
partial
cleavag
product
inde
subsequ
immunoblot
antibodi
reveal
smallest
kda
peptid
contain
ctermin
epitop
suggest
togeth
ntermin
kda
product
form
fulllength
protein
moreov
hypothes
two
intermedi
band
kda
detect
polyclon
antibodi
result
secondari
cleavag
larg
kda
fragment
especi
none
three
band
recogn
antibodi
accordingli
presenc
substanti
amount
kda
precursor
peptid
would
indic
particular
reaction
occur
ineffici
cleavag
site
access
subset
subunit
within
assembl
capsid
contrast
appar
twostep
cleavag
process
find
two
band
whose
size
add
fulllength
suggest
particular
serotyp
cleav
effici
idea
inde
confirm
cleavag
rate
two
vector
compar
partial
digest
increas
amount
cathepsin
b
intriguingli
level
reduc
readili
incub
amount
enzym
indic
capsid
cleavag
may
effici
figur
discuss
differenti
cleavag
rate
pattern
could
explain
differ
transduct
rate
kinet
seen
previou
studi
indic
despit
aav
capsid
process
endosom
particl
escap
compart
assembl
virion
thu
sought
investig
cathepsin
cleavag
affect
stabil
aav
capsid
assess
abil
differ
monoclon
antibodi
bind
either
digest
undigest
virion
end
aav
particl
serotyp
incub
cathepsin
b
indic
transfer
onto
nitrocellulos
membran
nondenatur
condit
control
includ
undigest
viral
sampl
incub
base
previou
report
treatment
trigger
dissoci
capsid
particl
detect
immunoblot
either
antibodi
former
bind
epitop
cterminu
inaccess
assembl
capsid
becom
avail
bind
capsid
protein
dissoci
contrast
antibodi
sole
bind
intact
capsid
threedimension
epitop
disrupt
subunit
protein
disassembl
interestingli
observ
differ
digest
undigest
sampl
antibodi
minim
amount
protein
recogn
case
figur
consist
result
obtain
strong
signal
sampl
antibodi
whose
specif
intact
particl
confirm
lack
reaction
heatdenatur
particl
slight
decreas
signal
intens
digest
sampl
perhap
owe
chang
virion
confirm
upon
cathepsin
cleavag
individu
capsid
protein
moreov
observ
upon
addit
cultur
cell
digest
gfp
vector
display
similar
even
slightli
higher
transduct
effici
compar
undigest
particl
data
shown
collect
data
strongli
suggest
aav
particl
remain
intact
cathepsin
cleavag
support
idea
process
lead
capsid
dissoci
rather
prerequisit
effici
downstream
process
virion
studi
perform
better
understand
transduct
mechan
aav
serotyp
current
preclin
develop
use
human
gene
therapi
key
compon
aav
transduct
abil
aav
capsid
interact
specif
host
protein
enabl
proper
uptak
traffick
uncoat
viru
date
small
number
host
protein
identifi
individu
serotyp
exclud
leav
us
limit
understand
mechan
behind
aav
transduct
yeast
twohybrid
screen
describ
report
identifi
number
protein
capabl
directli
interact
portion
capsid
help
shed
light
complex
process
lead
aav
gene
express
sever
previou
studi
indic
endosom
process
necessari
transduct
aav
famili
prototyp
whose
capsid
protein
sequenc
highli
homolog
interestingli
screen
recov
two
endosom
proteas
cathepsin
b
l
either
alon
tandem
act
uncoat
factor
number
virus
reoviru
sar
coronaviru
hepat
b
ebola
nipah
hendra
report
show
cathepsin
appear
play
similar
role
demonstr
proteas
bind
cleav
capsid
activ
import
effici
cellular
transduct
serotyp
result
also
indic
possibl
redund
function
two
proteas
cleav
capsid
protein
given
serotyp
similarli
moreov
cellular
transduct
reduc
cathepsin
inhibitor
abl
inhibit
cathepsin
b
l
effici
furthermor
assay
show
cellular
transduct
independ
protein
capsid
neither
bound
cleav
cathepsin
higher
dose
inhibitor
diminish
transduct
inhibit
profil
clearli
distinct
cathepsin
b
inhibitor
low
dose
report
inhibit
cathepsin
l
upon
dosag
escal
suggest
anoth
cellular
proteas
import
transduct
also
inhibit
test
higher
dose
clearli
mechan
transduct
differ
close
relat
seem
depend
cathepsin
b
l
effici
gene
express
demonstr
function
signific
cathepsin
transduct
valid
use
screen
substanti
fact
anoth
studi
show
addit
frequent
recov
clone
kda
laminin
receptor
also
involv
infect
demonstr
receptor
import
cellular
bind
transduct
vitro
vivo
provid
first
report
cellular
receptor
knowledg
previou
studi
identifi
protein
capabl
directli
bind
capsid
summar
figur
twohybrid
screen
help
uncov
protein
involv
extraand
intracellular
step
infect
ie
receptor
bind
endosom
process
despit
mani
similar
report
studi
previou
work
show
vivo
transduct
rate
much
robust
possibl
owe
faster
uncoat
rate
reach
maxim
express
level
rapidli
yield
higher
transduct
level
liver
interestingli
studi
demonstr
capsid
process
differ
certain
endosom
proteas
capsid
protein
appear
cleav
effici
singl
site
close
center
protein
wherea
two
distinct
cleavag
site
ctermin
site
cleav
effici
assay
ntermin
site
result
partial
digest
capsid
fragment
even
less
virion
incub
amount
enzym
kda
precursor
fragment
still
readili
visibl
upon
western
blot
analys
data
shown
addit
capsid
appear
cleav
cathepsin
quicker
aav
particl
incub
without
cathepsin
b
transfer
nitrocellulos
membran
nonreduc
condit
detect
immunoblot
recogn
intact
particl
monoclon
antibodi
capsid
denatur
min
also
includ
control
n
rate
indic
distinct
cathepsin
cleavag
may
account
differ
uncoat
transduct
effici
previou
studi
show
traffic
differ
subcompart
within
endosom
doseand
cell
linedepend
manner
cathepsin
b
l
report
local
mostli
late
endosom
lesser
degre
earli
endosom
manner
effici
aav
particl
process
may
depend
compart
shuttl
possibl
subset
intern
particl
get
cleav
cathepsin
b
l
wherea
remaind
process
differ
set
protein
previou
studi
report
although
particl
traffic
late
endosom
cell
much
lesser
degre
latter
partli
explain
less
permiss
infect
perhap
permiss
cell
line
aav
particl
traffic
frequent
late
endosom
capsid
cleav
even
effici
cathepsin
increas
coloc
endosom
compart
addit
ding
et
al
report
particl
shuttl
recycl
endosom
compet
transgen
express
per
genom
basi
late
endosom
author
specul
due
effici
process
recycl
endosom
cathepsin
b
l
report
present
compart
far
aav
particl
may
process
proteas
ubiquitinassoci
protein
present
subcompart
proteas
recov
screen
potenti
candid
activ
tabl
perhap
act
synergist
cathepsin
independ
compartmentspecif
fashion
twohybrid
screen
implic
number
protein
mani
differ
class
factor
abl
interact
capsid
screen
conduct
yeast
system
unlik
recov
gene
would
bind
intact
viru
mammalian
cellular
set
howev
use
number
independ
assay
show
screen
accur
predict
abil
capsid
bind
protein
convinc
us
analysi
recov
clone
clearli
warrant
although
studi
focus
protein
involv
aav
transduct
easi
envis
variou
protein
could
interact
aav
capsid
therebi
influenc
mani
addit
process
relev
aav
biolog
regul
capsid
synthesi
viral
replic
andor
viral
transmiss
addit
member
parvoviru
famili
share
mani
similar
aav
protein
identifi
screen
may
also
import
normal
function
analysi
protein
might
ultim
provid
valuabl
insight
treatment
virus
pathogen
viru
whose
infect
lead
fetal
loss
pregnant
women
caus
sever
anemia
immunocompromis
individu
summari
further
understand
transduct
identifi
number
candid
host
cell
protein
interact
capsid
reveal
import
sever
protein
transduct
studi
role
recov
clone
life
cycl
may
import
implic
use
power
gene
transfer
vector
plasmid
bait
plasmid
construct
first
pcr
amplifi
homolog
region
nucleic
acid
residu
aav
cap
gene
aav
helper
plasmid
pdg
respect
use
follow
primer
cggaattcgagca
ctctcctgtggagcca
cgggatccgctttgcccagatgggc
ccctg
cggaattcgaccactttccaaaaagaaag
ga
agatctacttggcccagatgggtccttg
cggaattcc
catcaccccagcgttctcca
gaagatctgcttggcccagatg
ggaccctg
pcr
product
digest
bamhi
ecori
bglii
ecori
ligat
bamhiecorilinear
plasmid
bd
clontech
palo
alto
ca
result
construct
cap
gene
fuse
infram
dnabind
domain
mous
cathepsin
b
l
cdna
amplifi
mous
liver
cdna
librari
bd
clontech
use
follow
primer
cathepsin
b
cggaattcaccatgtggtgg
tccttgatcct
ccgctcgagttagaatcttccccagtact
cathepsin
l
acgccaattgaccatgaatcttttactctttt
ccgctcgagtcaattcacgacaggatagc
cathepsin
b
l
pcr
product
digest
ecori
xhoi
mfei
xhoi
respect
clone
invitrogen
carlsbad
ca
vector
digest
ecori
xhoi
yeast
twohybrid
screen
initi
twohybrid
screen
conduct
use
bait
plasmid
mous
liver
matchmak
cdna
librari
bd
clontech
yeast
strain
mata
ua
tata
ua
tata
ua
tata
lacz
bd
clontech
clone
select
growth
sd
media
yeast
nitrogen
base
without
amino
acid
glucos
supplement
appropri
amino
acid
concentr
lack
shown
protein
recov
screen
subsequ
confirm
abil
bind
particl
laminin
receptor
act
cellular
receptor
serotyp
allow
bind
subsequ
enter
cell
particl
enter
endosom
cathepsin
b
l
bind
cleav
capsid
capsid
appear
cleav
differ
follow
particl
process
releas
endosom
traffic
nucleu
previous
shown
uncoat
readili
molecular
therapi
vol
feb
adenin
histidin
leucin
tryptophan
isol
plasmid
dna
yeast
cell
resuspend
ml
lysi
buffer
triton
sd
mm
nacl
mm
tri
ph
mm
edta
ph
addit
glass
bead
ml
phenol
vortex
min
cell
centrifug
min
rpm
dna
ethanol
precipit
aqueou
phase
resuspend
water
transform
escherichia
coli
librari
plasmid
dna
isol
sequenc
analyz
use
nation
center
biotechnolog
inform
blast
program
bgalactosidas
assay
activ
lacz
report
gene
determin
use
bgalactosidas
assay
chlorophenolreddgalactopyranosid
substrat
accord
bd
clontech
briefli
cell
grown
overnight
select
sd
media
lack
leucin
tryptophan
dilut
ypd
media
bactoyeast
extract
bactotrypton
glucos
h
od
yeast
cultur
measur
later
use
calcul
miller
unit
see
resuspend
cell
buffer
hepe
nacl
laspart
bsa
tween
subsequ
lyse
via
three
freezethaw
cycl
liquid
nitrogen
cprg
substrat
dissolv
concentr
buffer
ad
lyse
cell
reaction
stop
use
mm
zinc
chlorid
od
sampl
taken
calcul
miller
unit
od
time
min
od
aav
transduct
mammalian
cell
cell
per
well
grown
overnight
plate
dulbecco
modifi
eagl
medium
fetal
calf
serum
mm
lglutamin
antibioticantimycot
cell
transfect
cathepsin
b
l
express
vector
bd
clontech
use
polyfect
qiagen
valencia
ca
accord
manufactur
instruct
cell
incub
h
cathepsin
inhibitor
calbiochem
san
diego
ca
addit
gfp
vector
aav
gfp
vector
construct
consist
doublestrand
genom
express
gfp
gene
rou
sarcoma
viru
promot
describ
detail
elsewher
grimm
et
al
manuscript
prepar
briefli
engin
assembl
fulllength
itr
togeth
subfrag
invert
termin
repeat
pbluescriptii
stratagen
la
jolla
ca
backbon
fragment
contain
entir
itr
sequenc
except
termin
resolut
site
prevent
dna
nick
vector
dna
replic
dsaav
gfp
vector
plasmid
pseudotyp
three
differ
capsid
use
standard
tripl
plasmid
transfect
approach
viru
purifi
use
cesium
chlorid
densiti
gradient
centrifug
quantit
dot
blot
assay
result
viru
particl
ad
cell
follow
ratio
particlescel
gfp
gfp
cell
trypsin
h
later
analyz
fluorescentactiv
cell
sort
treatment
aav
purifi
cathepsin
mg
portion
purifi
bovin
spleen
cathepsin
b
mg
purifi
bovin
kidney
cathepsin
l
reaction
buffer
mm
sodium
acet
ph
mm
dithiothreitol
mg
human
recombin
cathepsin
reaction
buffer
mm
sodium
acet
ph
mm
dtt
calbiochem
san
diego
ca
usa
incub
particl
h
final
volum
ml
nmol
ad
individu
reaction
inhibit
cathepsin
b
l
activ
protein
denatur
boil
min
addit
laemmli
buffer
sampl
resolv
polyacrylamid
gel
analyz
immunoblot
antibodi
monoclon
antibodi
american
research
product
belmont
experi
shown
figur
recombin
particl
incub
increas
amount
cathepsin
b
ml
reaction
volum
h
